mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.02 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.1 |
0.03 |